We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SENEB:NASDAQSeneca Foods Corp. Analysis

Data as of 2026-06-12 - not real-time

$145.75

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Seneca Foods (SENEB) trades at $145.75, well below its DCF-derived fair value of $268, indicating a substantial upside potential. The stock benefits from a low beta (~0.02) and a moderate 30‑day volatility of 12%, suggesting limited market risk but some price swings. Fundamentals are solid: $1.61 B in revenue with modest 1.1% growth, healthy operating margins (~12.3%), ROE of 13.6% and a reasonable debt‑to‑equity ratio of 41%. Cash generation is strong, with $33 M cash on hand, $152 M free cash flow and a price‑to‑book of 1.39. Technicals show a bullish MACD crossover and price above the 20‑ and 50‑day SMAs, yet the RSI of 66 hints at short‑term overbought conditions and volume is decreasing, raising liquidity concerns.
The recent quarterly earnings release confirmed stable earnings and margins, reinforcing the defensive nature of the business. With no dividend, the appeal lies in value appreciation rather than income. Given the defensive consumer sector, low regulatory exposure, and international diversification, the stock presents a compelling long‑term buy at current levels, while short‑term traders may prefer to hold pending a clearer breakout or pull‑back.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD but RSI in overbought range
  • Price at immediate resistance level $145.75
  • Decreasing volume indicating liquidity pressure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to DCF fair value
  • Strong free cash flow and solid ROE
  • Defensive consumer sector with low beta

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Potential upside to fair value near $268
  • Stable margins and modest revenue growth
  • Diversified geographic footprint reducing concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth1.10%
Profit Margin5.58%
P/E Ratio11.2
ROE13.57%
ROA6.67%
Debt/Equity41.21
P/B Ratio1.4
Op. Cash Flow$206.0M
Free Cash Flow$151.8M

Technical Analysis

TrendNeutral
RSI66.2
Support$138.75
Resistance$145.75
MA 20$143.71
MA 50$143.79
MA 200$124.97
MACDBullish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Fair Value$268.22
GradeUndervalued
TypeValue

Risk Assessment

Beta0.02
Volatility12.05%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.